Concepedia

Alexandra d'Anglemont de Tassigny

AD

Statistics

Publications

8

Citations

286

H-Index

8

Active since

2001

Affiliations

Inserm(Current)

Hôpital Lariboisière

Université Paris-Est Créteil

Université Paris Cité

École Nationale Vétérinaire d'Alfort

Alexandra d'Anglemont de Tassigny is an author at Inserm specializing in apoptosis, life sciences, and pharmacology.

ORCID

Publications per year

2001–2013

8

Publications

8

Oxidative stress, mitochondrial permeability transition pore opening and cell death during hypoxia–reoxygenation in adult cardiomyocytes

Rana Assaly, Alexandra d'Anglemont de Tassigny, Stéphanie Paradis et al. · European Journal of Pharmacology · 2011 · 79 citations · Full text

, , +17

The Volume-Sensitive Chloride Channel Inhibitors Prevent Both Contractile Dysfunction and Apoptosis Induced by Doxorubicin Through PI3kinase, Akt and Erk 1/2

Alexandra d'Anglemont de Tassigny, Alain Berdeaux, Rachid Souktani et al. · European Journal of Heart Failure · 2008 · 52 citations

, , +16

Volume‐sensitive chloride channels (<i>I</i><sub>Cl,vol</sub>) mediate doxorubicin‐induced apoptosis through apoptotic volume decrease in cardiomyocytes

Alexandra d'Anglemont de Tassigny, Rachid Souktani, Patrick Henry et al. · Fundamental and Clinical Pharmacology · 2004 · 46 citations

, , +17

A Model of Hypoxia-Reoxygenation on Isolated Adult Mouse Cardiomyocytes

Lolita Portal, Valérie Martin, Rana Assaly et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 2013 · 45 citations

, , +10

Mitochondrial translocator protein (TSPO) ligands prevent doxorubicin-induced mechanical dysfunction and cell death in isolated cardiomyocytes

Alexandra d'Anglemont de Tassigny, Rana Assaly, Sophie Schaller et al. · Mitochondrion · 2013 · 27 citations · Full text

, , +17

1–5 of 8